The long-term level of functioning in patients admitted for psychotic disorders with and without substance abuse

References

• Blanchard JJ, Brown SE, Horan WP, Sherwood AR. Substance use disorders in schizophrenia: Review, integration, and a proposed model. Clin Psychol Rev 2000; 20: 207–34
   PubMed Web of Science ®Google Scholar
• Drake RE, Wallach M.A, Teague GB, Freeman DH, Paskus TS, Clark TA. Housing instability and homelessness among rural schizophrenic patients. Am J Psychiatry 1991; 148: 330–6
   PubMed Web of Science ®Google Scholar
• Soyka M, Albus M, Kathmann N, Finneli A, Hofstetter S, Holzbach R, et al. Prevalence of alcohol and drug abuse in schizophrenia inpatients. Eur Arch Psychiatry Clin Neurosci 1993; 242: 362–72
   PubMed Web of Science ®Google Scholar
• Seibyl JP, Satel SL, Anthony D, Southwick SM, Krystal JH, Charney DS. Effects of cocain on hospital course in schizophrenia. J Nerv Ment Dis 1993; 181: 31–7
   PubMed Web of Science ®Google Scholar
• Kovasznay B, Fleisher J, Tanenberg-Karant M, Jandorf L, Miller AD, Bromet E. Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 1997; 23: 195–201
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Jody D, Greisler S, Vital-Herne J, Alvir JMJ, Walsleben J, et al. Treatment outcome of first episode schizophrenia. Psychopharmacol Bull 1989; 25: 92–6
   PubMedGoogle Scholar
• Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and course of recent-onset of schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273–9
   PubMed Web of Science ®Google Scholar
• Sokolski KN, Cummings JL, Abrams BI, DeMet EM, Katz LS, Costa JF. Effects of substance abuse on hallucinations rates and treatment responses in chronic psychiatric patients. J Clin Psychiatry 1994; 55: 380–7
   PubMed Web of Science ®Google Scholar
• Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Jr, Davies JM, Lewis DA. Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 1995; 152: 856–61
   PubMed Web of Science ®Google Scholar
• Brady KT, Killeen T, Jarrell P. Depression in alcoholic schizophrenic patients. Am J Psychiatry 1993; 150: 1255–56
   PubMed Web of Science ®Google Scholar
• Cuffel BJ, Chase P. Remission and relapse of substance use disorders in schizophrenia: Results from a one-year prospective study. J Nerv Mental Dis 1994; 182: 342–8
   PubMed Web of Science ®Google Scholar
• Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443–55
   PubMed Web of Science ®Google Scholar
• Rasanen P, Tiihonen J, Isohanni M, Rantakallio P, Lehtonen J, Moring J. Schizophrenia, alcohol abuse, and violent behavior: A 26-year followup study of an unselected birth cohort. Schizophr Bull 1998; 24: 437–441
   PubMed Web of Science ®Google Scholar
• Abram KM, Teplin LA. Co-occuring disorders among mentally ill jail detainees: Implications for public policy. Am Psychol 1991; 46: 1036–45
   PubMed Web of Science ®Google Scholar
• Cohen LJ, Tests MA, Brown RJ. Suicide and schizophrenia: Data from a prospective community treatment study. Am J Psychiatry 1990; 147: 602–7
   PubMed Web of Science ®Google Scholar
• Landmark J, Cernofsky ZZ, Merskey H. Correlates of suicide attempts and ideation in schizophrenia. Br J Psychiatry 1987; 15: 18–20
   Google Scholar
• Dixon L, Haas G, Weiden P J, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am J Psychiatry 1991; 149: 224–30
   Google Scholar
• Arndt S, Tyrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse in schizophrenia: The role of pre-morbid adjustment. Psychol Med 1992; 22: 379–88
   PubMed Web of Science ®Google Scholar
• Sevy S, Kay SR, Opler LA, van Praag HM. Significance of cocaine history in schizophrenia. J Nerv Ment Dis 1990; 178: 642–8
   PubMed Web of Science ®Google Scholar
• Rosen A, Hadzi-Pavlovic D, Parker G. The Life Skills profile: A measure assessing function and disability in schizophrenia. Schizophr Bull 1989; 15: 325–37
   PubMed Web of Science ®Google Scholar
• Mueser KT, Drake RE, Clark RE, McHugo GJ, Mercer-McFadden, C, Ackerson TH. Toolkit for evaluating substance abuse in persons with severe mental illness; 1995.
   Google Scholar
• Barry KL, Fleming MF. The Alcohol Use Disorders Identification Test (AUDIT) and the SMAST-13: Predictive validity in a rural primary care sample. Alcohol Alcohol 1993; 28: 33–42
   PubMed Web of Science ®Google Scholar
• Gavin R, Skinner HA. Diagnostic validity of the Drug Abuse Screening Test in assessment of DSM-III drug disorders. Br J Addiction 1989; 84: 301–7
   PubMedGoogle Scholar
• Drake RE, Alterman AI, Rosenberg SD. Detection of substance use disorders in severely mentally ill patients. Community Ment Health J 1993; 29: 175–92
   PubMed Web of Science ®Google Scholar
• Staley D, El-Guebaly N. Psychometric properties of the Drug Abuse Screening Test in a psychiatric patient population. Addictive Behav 1990; 15: 257–64
   PubMed Web of Science ®Google Scholar
• Pulver AE, Wolyniec PC, Wagner MG, Moorman CC, McGrath JA. An epidemiological investigation of alcohol-dependent schizophrenics. Acta Psychiatr Scand 1989; 79: 603–12
   PubMed Web of Science ®Google Scholar
• Gershon ES, DeLisi LE, Hamovit J, Nurnberger JI, Maxwell ME, Schreiber J, et al. A controlled family study of chronic psychoses. Arch Gen Psychiatry 1988; 45: 328–36
   PubMed Web of Science ®Google Scholar
• Hays P, Aidroos N. Alcoholism followed by schizophrenia. Acta Psychiatr Scand 1986; 74: 187–9
   PubMedGoogle Scholar
• Kendler KS. A twin study of individuals with both schizophrenia and alcoholism. Br J Psychiatry 1985; 147: 48–53
   PubMed Web of Science ®Google Scholar
• Noordsy DL, Drake RE, Biesanz JC, McHugo GJ. Family history of alcoholism in schizophrenia. J Nerv Ment Dis 1994; 182: 651–5
   PubMed Web of Science ®Google Scholar